Rafferty Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Rafferty Asset Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,776	Closed	-$293K	–	1183
2024 Q3	$293K	Buy	+8,776	New	+$302K	﹤0.01%	1037

Rafferty Asset Management's LBPH Position: Q4 2024 in Review

Rafferty Asset Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 8,776 shares — an estimated $293K sold.

Rafferty Asset Management first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $293K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Rafferty Asset Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Rafferty Asset Management sold 8,776 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $293K.
Rafferty Asset Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Rafferty Asset Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $293K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Rafferty Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.